On 20 June, 2023(CET), 31st International Congress of the European Association for Endoscopic Surgery (EAES 2023) was opened at Rome, Italy. Medical technology company k8凯发国际官网入口 attended EAES 2023 and showcased its 4K UHD Fluorescence Imaging System, 3D Visualization System (Booth: E36), which reflects k8凯发国际官网入口's determination to its core strategy of  "globalization".

k8凯发国际官网入口@ EAES 2023

k8凯发国际官网入口 is a global medical technology company for minimally invasive diagnostics, establishing R&D centres in both China and Japan. Besides, k8凯发国际官网入口 has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas. The company aims to increase market penetration with excellent products and be the preferred brand trusted by doctors and patients around the world through the continuous improvement of its core technologies.

With solid in-house R&D capabilities, k8凯发国际官网入口 has built a unique technology platform based on five synergistic core technologies: 4K UHD medical imaging technology, Fluorescence medical imaging technology, 3D medical imaging technology, Ultrathin Endoscopic imaging technology and Single-use Endoscopic technology. With its comprehensive portfolio of endoscope products, k8凯发国际官网入口 aims to cover all types of endoscopic procedures and meet various medical needs in this field.

The 4K UHD Fluorescence Imaging System exhibited at EAES 2023 is developed by 4K UHD medical imaging technology and Fluorescence medical imaging technology from this unique technology platform. k8凯发国际官网入口 4K UHD Fluorescence combined with 3D Technology to obtain ultra-high-definition 3D images with fluorescence effect, which can be used in hepatobiliary surgery, thoracic surgery, gynecology, gastrointestinal surgery, and urology, etc.

"For us, the focus is always on the doctors and patients, for whom we want to provide optimal care. EAES 2023 is a great opportunity for k8凯发国际官网入口 to talk with world-class surgeon directly, to know more about local patients. " said Michael Li, Vice President of International Marketing & Sales. "In addition, we believed through this exhibition that we are able to make more local surgeon to know us and recognize us due to the high quality of our products.” Mr. Li continued.

About k8凯发国际官网入口

Founded in 2016, k8凯发国际官网入口 is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on the research, development and commercialization of medical endoscopes and related products. k8凯发国际官网入口 takes 'Globalization' as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, k8凯发国际官网入口 has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and products candidates covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering its value of 'Clinical Focus'  'Collaborative Innovation' 'People Oriented' 'Excellence & Efficiency', k8凯发国际官网入口 will continuously upgrade its core technologies, improve market penetration with excellent products, and to be the preferred brand trusted by doctors and patients around the world.

For more information, please visit: scivitamedical.com/#/

Press Contact:

k8凯发国际官网入口, WANG Ting

Tel: +86-512-8717 4749

Email: TingWang@scivitamedical.com